UNAUDITED CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)	Preferred Stock	Common Stock	Subscription Receivable	Common Stock Payable	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Sub Total	Noncontrolling Interest	Redeemable Noncontrolling Interest	Total
Balance at Jul. 31, 2018	$ 4	$ 31,402		$ 2,168,951	$ 368,379,293	$ (409,386,468)	$ 798,422	$ (38,008,396)	$ (5,576,272)		$ (43,584,668)
Balance (in shares) at Jul. 31, 2018	79,590	31,402,169
Investment in subsidiary by noncontrolling interest									133,679		133,679
Conversion of preferred series H	$ (3)	$ 28,829			(28,829)			(3)			(3)
Conversion of preferred series H (in shares)	(63,000)	28,828,953
Conversion of preferred series I	$ (1)	$ 7,584			(7,584)			(1)			(1)
Conversion of preferred series I (in shares)	(16,590)	7,583,560
Elimination of non-controlling interest					(6,951,015)			(6,951,015)			(6,951,015)
Issuance of common stock payable		$ 8,495		(1,967,657)	1,959,162
Issuance of common stock payable (in shares)		8,495,924
Issuance of stock options					924,845			924,845			924,845
Extinguishment of debt		$ 46			14,056,067			14,056,113			14,056,113
Extinguishment of debt (in shares)		46,033
Issuance of warrants					9,032,435			9,032,435			9,032,435
Acquisition of NCI of Veneto									51,090		51,090
Acquisition of NCI of Regentys									9,870,762		9,870,762
Acquisition of NCI of Olaregen									11,999,557		11,999,557
Acquisition of NCI of HDS									5,565,285		5,565,285
Redeemable non-controlling interest										4,073,898	4,073,898
Currency translation adjustment							2,024	2,024			2,024
Net Income (loss)						5,758,399		5,758,399	(360,403)		5,397,996
Balance at Jan. 31, 2019		$ 76,356		201,294	387,364,374	(403,628,069)	800,446	(15,185,599)	21,683,698	4,073,898	10,571,997
Balance (in shares) at Jan. 31, 2019		76,356,640
Balance at Oct. 31, 2018	$ 5	$ 39,798		251,617	370,391,425	(391,512,465)	800,048	(20,029,573)	(5,573,501)		(25,603,074)
Balance (in shares) at Oct. 31, 2018	79,590	39,797,869
Investment in subsidiary by noncontrolling interest									42,652		42,652
Conversion of preferred series H	$ (3)	$ 28,829			(28,829)			(3)			(3)
Conversion of preferred series H (in shares)	(63,000)	28,828,953
Conversion of preferred series I	$ (1)	$ 7,584			(7,584)			(1)			(1)
Conversion of preferred series I (in shares)	(16,590)	7,583,560
Elimination of non-controlling interest					(6,951,015)			(6,951,015)			(6,951,015)
Issuance of common stock payable		$ 99		(50,323)	50,224
Issuance of common stock payable (in shares)		100,225
Issuance of stock options					821,651			821,651			821,651
Extinguishment of debt		$ 46			14,056,067			14,056,113			14,056,113
Extinguishment of debt (in shares)		46,033
Issuance of warrants					9,032,435			9,032,435			9,032,435
Acquisition of NCI of Veneto									51,090		51,090
Acquisition of NCI of Regentys									9,870,762		9,870,762
Acquisition of NCI of Olaregen									11,999,557		11,999,557
Acquisition of NCI of HDS									5,565,285		5,565,285
Redeemable non-controlling interest										4,073,898	4,073,898
Currency translation adjustment							398	398			398
Net Income (loss)						(12,115,604)		(12,115,604)	(272,147)		(12,524,584)
Balance at Jan. 31, 2019		$ 76,356		$ 201,294	387,364,374	(403,628,069)	800,446	(15,185,599)	21,683,698	$ 4,073,898	10,571,997
Balance (in shares) at Jan. 31, 2019		76,356,640
Balance at Jul. 31, 2019		$ 78,608			408,550,211	(418,727,875)	797,216	(9,301,840)	16,974,439		7,672,599
Balance (in shares) at Jul. 31, 2019		78,608,419
Stock compensation expense					1,236,697			1,236,697			1,236,697
Shares issued for deferred offering		$ 1,720	(767,690)		765,970			767,690
Shares issued for deferred offering (in shares)		1,719,901
Shares issued for services		$ 560			243,040			243,600			243,600
Shares issued for services (in shares)		560,000
Issuance of common stock payable		$ 436			935,959			936,395			936,395
Issuance of common stock payable (in shares)		436,121
Conversion of debt to equity		$ 5,005			2,899,753			2,904,758			2,904,758
Conversion of debt to equity (in shares)		5,006,548
Issuance of common stock for acquisitions		$ 960			1,150,992			1,151,952			1,151,952
Issuance of common stock for acquisitions (in shares)		960,000
Reduction of derivative liabilities					2,276,078			2,276,078			2,276,078
Cancellation of shares		$ (20,376)			20,376
Cancellation of shares (in shares)		(20,375,900)
Purchase of shares in subsidiary		$ 1,906			1,985,484			1,987,390	(1,987,390)
Purchase of shares in subsidiary (in shares)		1,905,912
Shares issued in upon issuance of debt		$ 308			141,682			141,990			141,990
Shares issued in upon issuance of debt (in shares)		308,000
Redeemable non-controlling interest
Currency translation adjustment							(22,025)	(22,025)			(22,025)
Net Income (loss)						(16,035,448)		(16,035,448)	(557,129)		(16,592,577)
Balance at Jan. 31, 2020		$ 69,127	(767,690)		420,206,242	(434,763,323)	775,191	(14,480,453)	14,429,920		(50,533)
Balance (in shares) at Jan. 31, 2020		69,129,001
Balance at Oct. 31, 2019		$ 61,226			417,064,612	(427,853,820)	796,922	(9,931,060)	14,800,447		4,869,387
Balance (in shares) at Oct. 31, 2019		61,225,895
Stock compensation expense					449,239			449,239			449,239
Shares issued for deferred offering		$ 1,720	(767,690)		765,970			767,690
Shares issued for deferred offering (in shares)		1,719,901
Shares issued for services		$ 560			243,040			243,600			$ 243,600
Shares issued for services (in shares)		560,000									560,000
Issuance of common stock payable		$ 33			14,468			14,501			$ 14,501
Issuance of common stock payable (in shares)		32,611
Conversion of debt to equity		$ 3,374			1,164,546			1,167,920			1,167,920
Conversion of debt to equity (in shares)		3,376,682
Issuance of common stock for acquisitions
Reduction of derivative liabilities					364,591			364,591			364,591
Purchase of shares in subsidiary		$ 1,906			(1,906)
Purchase of shares in subsidiary (in shares)		1,905,912
Shares issued in upon issuance of debt		$ 308			141,682			141,990			$ 141,990
Shares issued in upon issuance of debt (in shares)		308,000									308,000
Currency translation adjustment							(21,731)	(21,731)			$ (21,731)
Net Income (loss)						(6,909,503)		(6,909,503)	(370,527)		(7,280,030)
Balance at Jan. 31, 2020		$ 69,127	$ (767,690)		$ 420,206,242	$ (434,763,323)	$ 775,191	$ (14,480,453)	$ 14,429,920		$ (50,533)
Balance (in shares) at Jan. 31, 2020		69,129,001